Italy-Based Cultipharm Raises €1M Funding

The company will use the funds to support strategic initiatives across its core operations.

Led by Massimo and Emanuele Lucchini, along with Alessandro Algeri, Cultipharm focuses on producing and customizing botanicals and active ingredients using vertical farming and a botanical bio-workshop model to power next-generation production systems.

The company has also developed an advanced research method that uses its in-house laboratory to treat each plant as a natural lab for active ingredients. This setup enables precise control or optimization of growth variables ensuring a consistent and reproducible phytochemical profile.

Read Also - Bitzero Raises $25M To Scale Clean Blockchain Mining With Next-Gen Mining Deployment

Cultipharm is pioneering the future of botanical production through vertical farming, specializing in the cultivation of botanicals and active ingredients for the pharmaceutical, nutraceutical and cosmetic industries.

By leveraging a soilless, stacked-layer farming system, the company creates fully controlled environments that ensure optimal plant growth and exceptional quality.

Cultipharm’s research driven approach involves a deep analysis of plant balsamic times and the effects of chemical and physical growth conditions. This scientific precision has enabled the creation of Superactives highly concentrated customizable extracts designed to meet the specific demands of various industries.

With plants at the center and technology as an enabler, Cultipharm is reshaping sustainable agriculture while offering traceable, high-performance botanical solutions.